Saccharomyces boulardii Probiotic Supplement clinical trials
How each study uses Saccharomyces boulardii Probiotic Supplement is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Saccharomyces boulardii Probiotic Supplement studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Saccharomyces Boulardii Probiotic Supplement
- 3
Studies by the year they started
3 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2021 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
Aswan University Hospital (1) · I.M. Sechenov First Moscow State Medical University (1) · Can Tho University of Medicine and Pharmacy (1)
Studies
Open first, then newest update. How each study uses Saccharomyces boulardii Probiotic Supplement is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy and Safety of Saccharomyces Boulardii in Treatment of Acute Diarrhea in Children Aged 6 Months to 5 Years OldNot yet recruitingNot applicableCan Tho University of Medicine and PharmacyNCT07813182Written as Saccharomyces Boulardii Probiotic Supplement
- Probiotics and Post-Pullthrough Hirschsprung's Disease-Associated EnterocolitisCompletedNot applicableAswan University HospitalNCT07098494Written as Saccharomyces Boulardii Probiotic Supplement
- Probiotics and Hemodynamic Changes in CirrhosisCompletedNot applicableI.M. Sechenov First Moscow State Medical UniversityNCT05231772Written as Saccharomyces Boulardii Probiotic Supplement